Rettori V, Rubio M, Seilicovich A, Malik A, de los Santos A
Neuropsychobiology. 1983;10(4):209-12. doi: 10.1159/000118013.
The effect of nomifensine on plasma levels of cortisol, prolactin, dopamine, noradrenaline, adrenaline and serotonin were studied in neurotic depressive patients. Cortisol levels were elevated in the morning and were significantly decreased by nomifensine treatment. Prolactin levels were within the normal range and nomifensine did not modify them. A significative increase in catecholamine plasma levels was observed at the 6th week of treatment in depressed patients (dopamine: 106%; noradrenaline: 14%; adrenaline: 10%) whose nomifensine plasma levels ranged between 84 and 105 ng/ml. No statistical differences were found between pre- and post-treatment serotonin concentration. Reduction of plasma cortisol and clinical improvement may be related to increased catecholamine levels.
研究了诺米芬辛对神经症性抑郁患者血浆皮质醇、催乳素、多巴胺、去甲肾上腺素、肾上腺素和血清素水平的影响。皮质醇水平在早晨升高,经诺米芬辛治疗后显著降低。催乳素水平在正常范围内,诺米芬辛未对其产生影响。在治疗第6周时,血浆儿茶酚胺水平在血浆诺米芬辛水平介于84至105 ng/ml之间的抑郁患者中显著升高(多巴胺:106%;去甲肾上腺素:14%;肾上腺素:10%)。治疗前后血清素浓度未发现统计学差异。血浆皮质醇的降低和临床改善可能与儿茶酚胺水平升高有关。